ClinicalTrialsFinder

Gangliosidosis Clinical Trials in Bethesda, Maryland

1 recruitingBethesda, Maryland

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis

Lysosomal DiseasesGangliosidosisGM1
National Human Genome Research Institute (NHGRI)54 enrolled1 locationNCT03952637